Arrhythmogenic Cardiomyopathy Gene Mutation Panel, NGS
Cardiomyopathies are a group of heart diseases characterized by myocardial dysfunction. There are inherited cardiomyopathies caused by inherited, genetic factors and acquired cardiomyopathies caused by environmental factors such as infection or trauma. The inherited forms of cardiomyopathy include hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and left ventricular noncompaction cardiomyopathy (LVNC).
Arrhythmogenic right ventricular cardiomyopathy (ARVC) also known as arrhythmogenic right ventricular dysplasia is a disorder characterized by myocyte loss, replacement of the normal myocardium by fibrofatty tissue, and right ventricular wall thinning. ARVC is a cause of sudden cardiac deaths in young people and including athletes.
The estimated prevalence of ARVC has been reported as high as 1 in 10,000. Most affected individuals present with heart palpitations, syncope, or sudden cardiac death between the second and fifth decade of life. Diagnostic criteria for ARVC were established by McKenna et al in 1994, and were revised in 2010. The diagnostic approach includes electrocardiographic findings, presence of arrhythmias, structural defects, histopathological features, and genetic/family history information.
ARVC is typically considered a disease of the desmosome, the structure that attaches heart muscle cells to one another. The desmosome provides strength to the muscle tissue and plays a role in signaling between neighboring cells. Gene mutation associated with ARVC disrupt this function, causing detachment and death of myocardial cells when the heart muscle is under stress. Damaged myocardium is replaced with fat and scar tissue, eventually leading to structural and electrical abnormalities that can lead to arrhythmia. ARVC is primarily associated with mutations in the desmosomal genes JUP, DSP, DSC2, DSG2, and PKP2; however, mutations in several nondesmosomal genes have also been described. Inheritance of ARVC typically follows an autosomal dominant pattern of inheritance, and variants in DSC2, DSP, and PKP2 account for approximately half of the variants identified in ARVC. However, simultaneous testing of all known ARVC genes is recommended due to the potential for compound heterozygosity or digenic heterozygosity. This panel includes most common gene variations associated with ARVC and other cardiomyopathies and includes desmosome and non- desmosome genes. Here are most important genes responsible for ARVC phenotypes.
PKP2 is on of the desmosome genes family associated with ARVC. PKP2 gene encodes plakophilin-2, a protein with structure similar to that of plakoglobin which is encoded by JUP gene. JUP gene encodes plakoglobin which is a junction protein also associated with ARVC; however, the mutation frequency of JUP gene in ARVC is low compared to that of other desmosome genes.
DSP is the largest among the desmosome genes that encodes Desmoplakin, a protein required for localization to the desmosome and interaction with plakophilin, plakoglobin and desmin.
DSG2 and DSC2 are genes that encode cadherin-like transmembrane glycoproteins Desmoglein and Desmocollin that are major components of the desmosome. Mutations in both genes have been reported as the cause of ARVC.
RYR2 gene encodes the cardiac ryanodine receptor located to the sarcoplasmic reticulum, which plays role in cardiac contraction by controlling the calcium ions. Although, mutations in RYR2 gene are closely associated with ARVC, mutations in RYR2 were reported in various other cardiac diseases.
LMNA gene encodes laminA/C, which functions in the lining of the nuclear membrane and is responsible for stabilization of cells. LMNA mutations are not specific for ARVC and were reported in other cardiac and systemic diseases.
TMEM43 gene encodes transmembrane protein 43 which functions as a nuclear membrane organizer. Mutation in TMEM43 are rare compare to desmosome mutation but the pathogenesis might be different of those desmosome mutations. One of these differences includes the early onset of ARVC.
Another important gene responsible for ARVC is TTN that encodes Titin protein, which is another large structural protein of heart muscle. Mutation in Titin protein is associated with ARVC and various mutations display different phenotypes, including biventricular dysfunction and conduction block. Mutations on these genes are detected by next generation sequencing and confirmed by conventional sequencing.
- As an aid in diagnosis of arrhythmogenic right ventricular cardiomyopathy
- Risk evaluation and carrier screening for mutation in at-risk family members
If pathogenic variants are identified it will be listed and clinical interpretation will be given following AMCG report and interpretation guidelines.
For example;
Gene (Transcript): PKP2 (NM_004572.3)
Genomic position: g.33031955
cDNA change: c.235C>T
Amino acid change: p.Arg79X
Classification: Pathogenic
The patient is heterozygous for this variant.
- The c.235C>T (p.Arg79X) variant in the PKP2 (NM_004572.3) gene is a known pathogenic variant
- The finding of a pathogenic variant is supportive of a diagnosis of a hereditary form of cardiomyopathy for this individual but should be correlated with clinical findings
No pathogenic variants detected (Negative for mutations analyzed)
Whole Blood EDTA (lavender top tube).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- J Arrhythm. 2016 Oct;32(5):398-403. [PMID: 27761164]
- Circ Res. 2017 Sep 15;121(7):784-802. [PMID: 28912183]
- J Cardiovasc Med (Hagerstown). 2016 Jun;17(6):399-407. [PMID: 26990921]
- J Am Coll Cardiol. 2007 Nov 6;50(19):1813-21. [PMID: 17980246]
- Cardiovasc Res [. 2017 Oct 1;113(12):1521-1531. [PMID: 28957532]
- J Am Coll Cardiol. 2013 May 14;61(19):1945-8. [PMID: 23500315]